There are counterfeits now: off-color labels, wrong date formatting, faded text
Why GLP-1 Medications Cause GI Issues GLP-1 medications like semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), and tirzepatide (Mounjaro, Zepbound) are effective for managing type 2 diabetes and aiding weight loss, but up to 40% of patients experience gastrointestinal (GI) side effects
An exceptionally low initiation rate was observed even in this potentially advantaged population suggests GLP-1 RA initiation rates in the broader Polish population may be equally concerning, if not worse
Exercise benefits extend beyond improvements in liver outcomes, and have been shown to provide cardiovascular benefits, which is important as cardiovascular disease is a leading cause of death in this population
Consequently, no full texts were assessed, and no studies were included
Tesamorelin was developed right here in Canada by Theratechnologies, a Montreal-based biotech company